...
首页> 外文期刊>European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology >Necrolytic migratory erythema, first symptom of a malignant glucagonoma: treatment by long-acting somatostatin and surgical resection. Report of three cases.
【24h】

Necrolytic migratory erythema, first symptom of a malignant glucagonoma: treatment by long-acting somatostatin and surgical resection. Report of three cases.

机译:坏死性迁徙性红斑,恶性胰高血糖素瘤的首发症状:长效生长抑素和手术切除治疗。报告三例。

获取原文
获取原文并翻译 | 示例
           

摘要

We report three cases of malignant glucagonoma with necrolytic migratory erythema as the first clinical symptom. Long-acting somatostatin analogue was the first step of a multimodal therapeutic strategy which included surgical resection of the primary tumour in every case. Liver metastases which were present in two patients were treated by hepatic arterial chemoembolization and systemic chemotherapy in one case and by liver resection for cytoreduction and hepatic arterial chemoembolization in another case. Skin lesions resolved in all three patients.
机译:我们报告三例恶性胰高血糖素血症伴坏死性迁徙性红斑为首例临床症状。长效生长抑素类似物是多模式治疗策略的第一步,该策略包括在每种情况下均手术切除原发肿瘤。两名患者存在肝转移,其中一例行肝动脉化疗栓塞和全身化疗,另一例行肝切除术以减少细胞和肝动脉化疗栓塞。所有三名患者的皮肤病变均已消除。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号